DNAprint Genomics (DNAG)

[stakddek]

Okay. Dumb Question Time:

Should DNAP consider Genelink as an acquisition target. They appear ripe and it does broaden our markets.

Thanks for info on 02. cent shares being consolidated along with the rest of us. I take the 8k as Gospel on the initial payment. I was unsure how the 02 cents would be handled.

Expectation of revenue from Trace: If they are willing to sell it to DNAP at what appear to be very favorable terms, and DNAP is keeping the principals and main employees on board, is it safe to assume that the revenues for Trace are not earth shaking? If so DNAP does not have an expectation of revenue from Trace, unless synergy produces volume that requires the DNAP facility to shoulder the overflow. Obviously the addittion of the two reknowned individuals to the DNAP stable of talent is not to be sneared at. That may be worth the money by itself. The DNAP west (Trace) will have to be self supporting, but as a certified location, under new ownership but with the same management and employees, that may not be any speed bump.

I wonder if there is a blockbuster being held for the shareholder meeting.

It was nice to hear Doctor Gabriel mention Doctor Frudakis during his interview. Two patent refusals to appeal. Doctor Frudakis has many more busy days ahead!

Stakddek